
You can purchase shares of Apollomics (NASDAQ:APLMW) through any online brokerage.
Other companies in Apollomics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
There is no analysis for Apollomics to provide a consensus price target.
The stock price for Apollomics (NASDAQ: APLMW) is $0.0103 last updated November 12, 2026 at 9:45 AM EST.
There are no upcoming dividends for Apollomics.
Apollomics does not have any upcoming earnings scheduled.
There is no upcoming split for Apollomics.
Apollomics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular...